198905-40-7

Basic information

• Product Name: 2-(3-methoxyphenoxy)acetamide
• Synonyms: 2-(3-methoxyphenoxy)acetamide
• CAS NO: 198905-40-7
• Molecular Weight: 181.191
• Mol File: 198905-40-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-(3-methoxyphenoxy)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-methoxyphenoxy)acetamide(198905-40-7)
• EPA Substance Registry System: 2-(3-methoxyphenoxy)acetamide(198905-40-7)

Safety Data

• Hazardous Substances Data: 198905-40-7(Hazardous Substances Data)

Upstream product

• 2088-24-6 3-methoxyphenoxyacetic acid 
• 82815-86-9 (3-methoxy-phenoxy)-acetic acid ethyl ester 
• 1122-95-8 sodium 4-methoxyphenolate 
• 79-07-2 Chloroacetamide 
• 150-19-6 O-methylresorcine 
• 683-57-8 bromo-acetic acid amide 

Downstream Products

• 6487-86-1 2-(3-methoxyphenoxy)ethanamine 
• 71706-89-3 1-(3-methoxy-phenoxy)-3-phenyl-acetone semicarbazone 
• 71706-76-8 1-(3-methoxy-phenoxy)-3-phenyl-acetone 
• 50635-23-9 (3-methoxyphenoxy)acetonitrile 

Relevant articles and documents

Polymer supported bases in combinatorial chemistry: Synthesis of aryl ethers from phenols and alkyl halides and aryl halides

Polymer supported 1,5,7-triazabicyclo[4.4.0]dec-5-ene (PTBD) was used as a base and a reagent scavenger for rapid synthesis of aryl ethers from phenols and alkyl or aryl halides. This method provides a simple reaction operation, and generally high purity of reaction product in good yield.

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The invention relates to the field of medicine, discloses new nitrogen heterocyclic derivatives, preparation method thereof and as medicament in particular as the treatment and prevention of treating tissue fibrosis of the medicament. The invention also discloses a pharmaceutically acceptable compound of the present invention comprise a pharmaceutical composition and methods for using the composition for the treatment of the human or animal tissue fibrosis of diseases, in particular for treating the human or animal renal interstitial fibrosis, glomerular sclerosis, hepatic fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, skin fibrosis, after the operation of adhering, benign prostate hypertrophy, bone-myocardial, scleroderma, multiple sclerosis, pancreas fibrosis, liver cirrhosis, myosarcoma, neurofibromatosis, interstitial pulmonary fibrosis, diabetic nephropathy, Alzheimer's disease or vascular fibrosis disease in use. (by machine translation)

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.